NasdaqCM - Delayed Quote • USD
MiMedx Group, Inc. (MDXG)
At close: April 25 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 5 | 5 |
| Avg. Estimate | 0.04 | 0.08 | 0.31 | 0.39 |
| Low Estimate | 0.03 | 0.07 | 0.28 | 0.35 |
| High Estimate | 0.06 | 0.1 | 0.35 | 0.44 |
| Year Ago EPS | -0.06 | 0 | 0.37 | 0.31 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | 79.36M | 89M | 357.12M | 403.37M |
| Low Estimate | 79M | 87M | 354.1M | 392.1M |
| High Estimate | 80M | 91M | 363.21M | 419.19M |
| Year Ago Sales | 64.15M | 81.26M | 321.48M | 357.12M |
| Sales Growth (year/est) | 23.70% | 9.50% | 11.10% | 13.00% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.09 | -0.02 | 0.04 | 0.07 |
| EPS Actual | -0.06 | 0 | 0.06 | 0.32 |
| Difference | 0.03 | 0.02 | 0.02 | 0.25 |
| Surprise % | 33.30% | 100.00% | 50.00% | 357.10% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.04 | 0.08 | 0.31 | 0.39 |
| 7 Days Ago | 0.04 | 0.08 | 0.31 | 0.39 |
| 30 Days Ago | 0.04 | 0.08 | 0.31 | 0.39 |
| 60 Days Ago | 0.04 | 0.08 | 0.31 | 0.44 |
| 90 Days Ago | 0.04 | 0.08 | 0.31 | 0.44 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | MDXG | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 166.70% | -- | -- | 2.60% |
| Next Qtr. | -- | -- | -- | 13.40% |
| Current Year | -16.20% | -- | -- | 5.20% |
| Next Year | 25.80% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 15.00% | -- | -- | 11.11% |
| Past 5 Years (per annum) | 31.85% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Initiated | Lake Street: Buy | 3/7/2024 |
| Maintains | Mizuho: Buy to Buy | 3/1/2024 |
| Maintains | Mizuho: Buy to Buy | 10/31/2023 |
| Initiated | Craig-Hallum: Buy | 10/27/2023 |
| Maintains | Mizuho: Buy to Buy | 8/2/2023 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/2/2023 |
Related Tickers
PTGX Protagonist Therapeutics, Inc.
24.66
-4.05%
PTCT PTC Therapeutics, Inc.
25.49
+1.11%
PRTA Prothena Corporation plc
20.56
0.00%
ENTA Enanta Pharmaceuticals, Inc.
12.48
-3.41%
ITOS iTeos Therapeutics, Inc.
10.60
+0.28%
RKVTF RAKOVINA THERAPEUTICS INC
0.0600
0.00%
PCVX Vaxcyte, Inc.
60.06
-0.40%
CGEN.TA Compugen Ltd.
764.00
+1.93%
LYRA Lyra Therapeutics, Inc.
5.17
-1.15%
MGNX MacroGenics, Inc.
14.37
-8.47%